CT perfusion of liver metastases and early detection of micrometastases

Multi-Detector Computed Tomography in Oncology: CT Perfusion Imaging

Volumn , Issue , 2007, Pages 173-196

  Cuenod, Charles André ^a   Fournier, Laure ^a   Balvay, Daniel ^a   Miles, Kenneth A ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79251575750     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Paley MR, Ros P. Hepatic metastases. Radiol Clin North Am 1998; 36: 349-363.
2. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995; 197: 329-37.
3. Finlay IG, McArdle CS. Occult metastases in colorectal carcinoma. Br J Surg 1986; 73: 732-5.
4. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002; 224: 748-56.
5. Greenway B. Hepatic metastases from colorectal cancer: resection or not. Br J Surg 1988; 75: 513-19.
6. Moertel CG. Drug therapy: chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1136-42.
7. Cooke DA, Parkin A, Wiggins P, Robinson PJ, Giles GR. Hepatic perfusion index and the evolution of liver metastases. Nucl Med Commun 1987; 8: 970-4.
8. Nott DM, Grime JS, Yates J et al. Changes in the hepatic perfusion index during the growth and development of experimental hepatic micrometastases. Nucl Med Commun 1987; 8: 995-1000.
9. Perkins AC, Whalley DR, Ballantyne KC, Hardcastle JD. Reliability of the hepatic perfusion index for the detection of liver metastases. Nucl Med Commun 1987; 8: 982-9.
10. Leen E, Goldberg JA, Robertson J et al. Image-directed Doppler ultrasonography: a novel technique for the diagnosis of colorectal liver metastases. J Clin Ultrasound 1993; 21: 221-30.
11. Platt JF, Francis IR, Ellis JH, Reige KA. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phased helical CT. Radiology 1997; 205: 49-53.
12. Thimgan MS, Yee HF Jr. Quantitation of rat hepatic stellate cell contraction: stellate cells, contribution to sinusoidal resistance. Am J Physiol Gastrointest Liver Physiol 1999; 277: 137-43.
13. Shah V, Haddad FG, Garcia-Cardena G, et al. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 1997; 100: 2923-30.
14. Lautt WW, Legare DJ, Almeida MS. Adenosine as putative regulator of hepatic arterial flow (the buffer reponse). Am J Physiol 1985; 248: 331-8.
15. Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996; 74: 223-33.
16. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology. 2005; 234: 661-73.
17. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188: 405-11.
18. Dugdale PE, Miles KA. Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. Eur J Radiol 1999; 30: 206-13.
19. Blomley M, Coulden R, Dawson P. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995; 19: 424-33.
20. Tsushima Y, Blomley JK, Kusano S, Endo K. The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 1999; 44: 1632-8.
21. Miles KA, McPherson SJ, Hayball MP. Transient splenic inhomogeneity on contrast enhanced CT: mechanism and effect of liver disease. Radiology 1995; 194: 91-5.
22. Leggett DA, Kelley BB, Bunce IH, Miles KA. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 1997; 205: 716-20.
23. Miles KA, Leggett DA, Kelley BB et al. In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 1998; 71: 276-81.
24. Halavaara JT, Hamberg LM, Leong FS et al. Functional CT with an experimental intravascular contrast agent in the assessment of liver vascular physiology. Acad Radiol 1996; 3: 946-52.
25. Materne R, Van Beers BE, Smith AM et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input onecompartmental model. Clin Sci (Lond) 2000; 99: 517-25.
26. Van Beers BE, Leconte I, Materne R et al. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001; 176: 667-73.
27. Cuenod C, Leconte I, Siauve N et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001; 218: 556-561.
28. Cuenod CA, Leconte I, Siauve N et al. Deconvolution technique for measuring tissue perfusion by dynamic CT: application to normal and metastatic liver. Acad Radiol 2002; 9: S205-11.
29. Fournier LS, Cuenod CA, de Bazelaire C et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol 2004; 14: 2125-33.
30. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol 1983; 18: 94-19.
31. Zierler KL. Equation for measuring blood flow by external monitoring of radioisotopes. Circ Res 1965; 16: 309-21.
32. Miles KA, Kelley BB. Altered perfusion adjacent to hepatic metastases. Clin Radiol 1997; 52: 162-3.
33. Tsushima Y, Blomley MJ, Yokoyama H, Kusano S, Endo K. Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver? Dig Dis Sci 2001; 46: 2113-19.
34. Desch CE, Benson AB 3rd, Somerfield MR et al. American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol, 2005; 23: 8512-19.
35. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cance. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-94.
36. Garcea G, Sharma RA, Dennison A et al. Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention. Eur J Cancer 2003; 39: 1041-52.
37. Smith JJ, Sorensen AG, Thrall JH. Biomarkers in imaging: realizing radiology’s future. Radiology 2003; 227: 633-8.
38. Mooteri S, Rubin D, Leurgans S et al. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 1996; 39: 1073-80.
39. Miles KA, Colyvas K, Griffiths MR, Bunce IH. Colon cancer: Risk stratification using hepatic perfusion CT. European Radiology 2004; 14: Suppl 2, 129.
40. Fuentes MA, Keith CJ, Griffiths M, Durbridge G, Miles KA. Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices. Br J Radiol 2002; 75: 17-23.
41. Ballantyne KC, Charnley RM, Perkins AC et al. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun 1990; 11: 23-8.
42. Hugier M, Maheswari S, Toussaint P et al. Hepatic flow scintigraphy in evaluation of hepatic metastases with gastrointestinal malignancy. Arch Surg 1993; 128: 1057-9.
43. Carter R, Hemingway D, Cooke TG et al. A prospective study of six methods for detection of hepatic colorectal metastases. Ann R Coll Surg Engl 1996; 78: 27-30.
44. Leen E, Goldberg JA, Anderson JR et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993; 34: 554-7.
45. Kissel A, Rixe O, Methlin A et al. Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers. J Radiol 2001; 82: 1621-5.
46. Leen E, Goldberg JA, Angerson WJ, McArdle CS. Potential role of Doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000; 355: 34-37.
47. Roumen RM, Scheltinga MR, Slooter GD, van der Linden AW. Doppler perfusion index fails to predict the presence of occult hepatic colorectal metastases. Eur J Surg Oncol 2005; 31: 521-7.
48. Yarmenitis SD, Kalogeropoulou CP, Hatjikondi O et al. An experimental approach of the Doppler perfusion index of the liver in detecting occult hepatic metastases: histological findings related to the hemodynamic measurements in Wistar rats. Eur Radiol 2000; 10: 417-24.
49. Totman JJ, O’Gorman RL, Kane PA, Karani JB. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol 2005; 78: 105-9.
50. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-77.
51. Fong Y. Doppler perfusion index in colorectal cancer. Lancet 2000; 355: 5-6.
52. Warren HW, Anderson WJ, Leen E et al. Haemodynamic changes associated with colorectal liver metastases: evidence of a humoral mediator. Br J Surg 1993; 80: 1561(abstr).
53. Carter R, Anderson JH, Cooke TG, Baxter JN, Angerson WJ. Splanchnic blood flow changes in the presence of hepatic tumour: evidence of a humoral mediator. Br J Cancer 1994; 69: 1025-6.
54. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly J. Perfusion of colorectal hepatic metastases: relative distribution from the hepatic artery and portal vein. Cancer 1987; 59: 1547-53.
55. Kan Z, Ivancev K, Lunderquist A et al. In vivo microscopy of hepatic tumors in animal model: a dynamic investigation of blood supply to hepatic metastases. Radiology 1993; 187: 621-6.
56. Morris VL, MacDonald IC, Koop S et al. Early interaction of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis 1993; 11: 377-50.
57. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004; 231: 482-90.
58. Kopljar M, Brkljacic B, Doko M, Horzic M. Nature of Doppler perfusion index changes in patients with colorectal cancer liver metastases. J Ultrasound Med 2004; 23: 1295-300.
59. Tian JL, Zhang JS. Hepatic perfusion disorders: etiopathogenesis and related diseases. World J Gastroenterol 2006 May 28; 12: 3265-70.
60. Haugeberg G, Strohmeyer T, Lierse W. The vascularization of liver metastases. J Cancer Res Clin Oncol 1988; 114: 415-19.
61. Terayama N, Terada T, Nakanuma Y. A morphometric and immunohistochemical study on angiogenesis of human metastatic carcinomas of the liver. Hepatology 1996; 24: 816-19.
62. Takeda A, Stoeltzing O, Ahmad SA et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol 2002; 9: 610-16.
63. Bader TR, Grabenwoger F, Prokesch RW, Krause W. Measurement of hepatic perfusion with dynamic computed tomography: assessment of normal values and comparison of two methods to compensate for motion artifacts. Invest Radiol 2000; 35: 539-47.
64. Nakashige A, Horiguchi J, Tamura A et al. Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration. Br J Radiol 2004; 77: 728-34.
65. Kapanen MK, Halavaara JT, Hakkinen AM. Assessment of vascular physiology of tumorous livers: comparison of two different methods. Acad Radiol 2003; 10: 1021-9.
66. Kapanen MK, Halavaara JT, Hakkinen AM. Open four-compartment model in the measurement of liver perfusio. Acad Radiol 2005; 12: 1542-50. Erratum in: Acad Radiol 2006; 13: 270.
67. Jeffrey GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford: Update Software, 2003.